Smith A M, Klugman K P, Coffey T J, Spratt B G
Department of Medical Microbiology, School of Pathology, South African Institute for Medical Research, Johannesburg.
Antimicrob Agents Chemother. 1993 Sep;37(9):1938-44. doi: 10.1128/AAC.37.9.1938.
Streptococcus pneumoniae (the pneumococcus) is believed to have developed resistance to penicillin by the production of altered forms of penicillin-binding proteins (PBPs) that have decreased affinity for penicillin. Sixty-eight clinical isolates of serogroup 6 and 19 pneumococci (MICs, < 0.015 to 8 micrograms/ml) were randomly selected from hospitals across South Africa which are at substantial geographic distance from each other. The polymerase chain reaction was used to isolate the penicillin-binding domain of PBPs 2B and 2X from the chromosomal DNAs of the bacteria; the purified PBP DNA was digested with restriction enzymes, the fragments were end-labelled and separated on polyacrylamide gels, and the DNA fingerprints were visualized following autoradiography. Fingerprint analysis revealed that at least 19 PBP 2B gene variants occur in the serogroup 6 and 19 pneumococci. The PBP 2B gene revealed a uniform profile among penicillin-susceptible isolates, with variation from this profile occurring only in isolates for which MICs were > or = 0.06 micrograms/ml. Analysis of the PBP 2X gene revealed a greater diversity in the population with 26 variant genes, including some diversity among susceptible isolates. Discrete profiles of both genes were found only within narrow bands of the penicillin MIC, so that the gene pattern predicted the MIC. PBP 2X gene variation and the lack of variability among PBP 2B genes in pneumococci inhibited at low MICs confirm that PBP 2X alteration may be responsible for low-level penicillin resistance, while alterations in both PBP 2B and PBP 2X are required for high-level resistance. The extensive diversity of PBP genes in South African serogroup 6 and 19 strains suggests that altered PBP genes have arisen frequently in this population.
肺炎链球菌(肺炎球菌)被认为是通过产生对青霉素亲和力降低的青霉素结合蛋白(PBPs)的改变形式而对青霉素产生耐药性。从南非各地彼此相距甚远的医院中随机选取了68株6型和19型肺炎球菌临床分离株(最低抑菌浓度,<0.015至8微克/毫升)。采用聚合酶链反应从细菌的染色体DNA中分离PBPs 2B和2X的青霉素结合结构域;纯化的PBP DNA用限制性内切酶消化,片段进行末端标记并在聚丙烯酰胺凝胶上分离,放射自显影后观察DNA指纹图谱。指纹分析显示,6型和19型肺炎球菌中至少出现19种PBP 2B基因变体。PBP 2B基因在青霉素敏感分离株中显示出一致的图谱,仅在最低抑菌浓度≥0.06微克/毫升的分离株中出现与该图谱的差异。对PBP 2X基因的分析显示,该群体中具有更大的多样性,有26种变体基因,包括一些敏感分离株中的多样性。仅在青霉素最低抑菌浓度的窄带范围内发现了两个基因的离散图谱,因此基因模式可预测最低抑菌浓度。肺炎球菌中PBP 2X基因变异以及低最低抑菌浓度下PBP 2B基因缺乏变异性证实,PBP 2X改变可能是低水平青霉素耐药性的原因,而高水平耐药性则需要PBP 2B和PBP 2X两者都发生改变。南非6型和19型菌株中PBP基因的广泛多样性表明,改变的PBP基因在该群体中频繁出现。